motley fool

Shares of BioCryst Pop on Merger Termination, but Gains Are Temporary

Shares Of BioCryst Pop On Merger Termination, But Gains Are Temporary

Filed under: drug treatment news articles

I wrote this article myself, and it expresses my own opinions. … Considering that the merger with Presidio was highly reliant on a potential hepatitis C regimen combining drugs from both companies, the termination today makes sense. … The …
Read more on Seeking Alpha

 

It's Time We Get Serious About Faster Drug Approval

Filed under: drug treatment news articles

Today, I'm writing this article from the hospital bedside of my good friend Scott Cruz who's been battling brain cancer for 23 years, since he was just 3 years old. Roche's (NASDAQOTH: RHHBY ) Avastin was recently combined with his current treatment, …
Read more on Motley Fool

 

Rockwell Medical Readying 2 Drugs For Dialysis

Filed under: drug treatment news articles

I wrote this article myself, and it expresses my own opinions. I am not … With a fleet of more than 50 tractor trailers, the company sends boxes of dialysate powder to dialysis clinics across the country where they get mixed with water into a liquid …
Read more on Seeking Alpha

 

First to Phase 3! Whoopee?

Filed under: drug treatment news articles

For that to happen, Gilead is bringing in another drug, GS-5885. A phase 3 trial testing the combination of sofosbuvir and GS-5885 with and without ribavirin started last month. If the 12-week treatment is successful, the phase 3 program for the combo …
Read more on Motley Fool